دورية أكاديمية
Sarcoma classification by DNA methylation profiling in clinical everyday life: the Charité experience
| العنوان: | Sarcoma classification by DNA methylation profiling in clinical everyday life: the Charité experience |
|---|---|
| المؤلفون: | Roohani, Siyer, Ehret, Felix, Perez, Eilís, Capper, David, Jarosch, Armin, Flörcken, Anne, Märdian, Sven, Zips, Daniel, Kaul, David |
| سنة النشر: | 2022 |
| المجموعة: | FU Berlin: Refubium |
| مصطلحات موضوعية: | Sarcoma, Bone, Soft tissue, DNA methylation, Methylation profiling, Profiling, Classifier, Clinical experience, ddc:610 |
| الوصف: | Background: Sarcomas are a heterogeneous group of rare malignant tumors with more than 100 subtypes. Accurate diagnosis remains challenging due to a lack of characteristic molecular or histomorphological hallmarks. A DNA methylation-based tumor profiling classifier for sarcomas (known as sarcoma classifier) from the German Cancer Research Center (Deutsches Krebsforschungszentrum) is now employed in selected cases to guide tumor classification and treatment decisions at our institution. Data on the usage of the classifier in daily clinical routine are lacking. Methods: In this single-center experience, we describe the clinical course of five sarcoma cases undergoing thorough pathological and reference pathological examination as well as DNA methylation-based profiling and their impact on subsequent treatment decisions. We collected data on the clinical course, DNA methylation analysis, histopathology, radiological imaging, and next-generation sequencing. Results: Five clinical cases involving DNA methylation-based profiling in 2021 at our institution were included. All patients' DNA methylation profiles were successfully matched to a methylation profile cluster of the sarcoma classifier's dataset. In three patients, the classifier reassured diagnosis or aided in finding the correct diagnosis in light of contradictory data and differential diagnoses. In two patients with intracranial tumors, the classifier changed the diagnosis to a novel diagnostic tumor group. Conclusions: The sarcoma classifier is a valuable diagnostic tool that should be used after comprehensive clinical and histopathological evaluation. It may help to reassure the histopathological diagnosis or indicate the need for thorough reassessment in cases where it contradicts previous findings. However, certain limitations (non-classifiable cases, misclassifications, unclear degree of sample purity for analysis and others) currently preclude wide clinical application. The current sarcoma classifier is therefore not yet ready for a broad clinical ... |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| العلاقة: | https://refubium.fu-berlin.de/handle/fub188/41751Test; http://dx.doi.org/10.17169/refubium-41471Test |
| DOI: | 10.17169/refubium-41471 |
| DOI: | 10.1186/s13148-022-01365-w |
| الإتاحة: | https://doi.org/10.17169/refubium-41471Test https://doi.org/10.1186/s13148-022-01365-wTest https://refubium.fu-berlin.de/handle/fub188/41751Test |
| حقوق: | https://creativecommons.org/licenses/by/4.0Test/ |
| رقم الانضمام: | edsbas.3B22BA17 |
| قاعدة البيانات: | BASE |
| DOI: | 10.17169/refubium-41471 |
|---|